Atmos Energy Corporation vs TransMedics Group Inc — how do they compare? Atmos Energy Corporation trades at $168.76 (market cap $28.66B), while TransMedics Group Inc trades at $87 (market cap $3.02B). The key difference: Atmos Energy Corporation is far larger — about 9.5× TransMedics Group Inc's market cap, and Atmos Energy Corporation pays a 2.36% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| ATO | TMDX | |
|---|---|---|
Market Cap | $28.66B | $3.02B |
Sector | Utilities | Technology |
52-Week High | $192.25 | $150.42 |
52-Week Low | $162.44 | $61.99 |
Enterprise Value | $38.46B | $3.41B |
Dividend Yield | 2.36% | — |
Signals from Pluang's Aura AI — not financial advice
Atmos Energy (ATO) trades at $169.58, up 0.99% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported strong Q3 2026 earnings of $1.43 per share, beating estimates, and reaffirmed fiscal 2026 guidance. Revenue grew to $4.7 billion in 2025, with a net income margin of 28.5%, while the balance sheet shows $25.19 billion in total assets and manageable leverage.
The outlook is supported by consistent dividend payments and analyst consensus pointing to upside with a $190.57 price target. Key risks include high capital expenditure trends and interest rate sensitivity, but the utility's defensive profile and earnings momentum provide a stable investment case for income-focused shareholders.
TransMedics Group (TMDX) trades at $87.02, down 1.57% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators like RSI indicate overbought conditions near 78. Fundamentally, the company reported record Q2 2026 revenue but missed earnings estimates, with net income margin declining to 22.69% from 31.42% in 2025. Recent news highlights an ongoing investigation into fiduciary duties by Rosen Law Firm, adding uncertainty.
The outlook remains cautiously optimistic with a consensus price target of $99.57, implying 14% upside, supported by strong analyst buy ratings (69%). However, risks include earnings volatility, margin pressure from rising costs, and legal scrutiny. Investors should weigh robust revenue growth against execution risks and elevated valuation multiples like a P/E of 23.15.
Trailing returns across standard periods
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →